With a one year PEG ratio of 1,686.65, Lemaitre Vascular Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 97.63% of US stocks.
Price to trailing twelve month operating cash flow for LMAT is currently 30.53, higher than 86.11% of US stocks with positive operating cash flow.
With a year-over-year growth in debt of 1,091.05%, Lemaitre Vascular Inc's debt growth rate surpasses 98.18% of about US stocks.
Stocks that are quantitatively similar to LMAT, based on their financial statements, market capitalization, and price volatility, are SSD, SSTK, ATRI, PLPC, and CRTO.
LMAT's SEC filings can be seen here. And to visit Lemaitre Vascular Inc's official web site, go to www.lemaitre.com.
LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease. The company was founded in 1983 and is based in Burlington, Massachusetts.
LMAT Price Forecast Based on DCF Valuation
DCF Fair Value Target:
We started the process of determining a valid price forecast for Lemaitre Vascular Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Lemaitre Vascular Inc ranked in the 51th percentile in terms of potential gain offered. More precisely, our analysis suggests the stock is undervalued by approximately 19.67% on a DCF basis. As for the metrics that stood out in our discounted cash flow analysis of Lemaitre Vascular Inc, consider:
The business' balance sheet reveals debt to be 9% of the company's capital (with equity being the remaining amount). Approximately merely 22.32% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
The company's cost of debt, derived from its interest coverage, tax rate, and market capitalization, is greater than just 0% of stocks in its sector (Healthcare).
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
Want more companies with a valuation profile/forecast similar to that of Lemaitre Vascular Inc? See EGRX, SNY, AMED, FONR, and CBPO.
BURLINGTON, Mass., July 29, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in August. JJ Pellegrino, Chief Financial Officer, is scheduled to present at the virtual Canaccord Genuity 40th Annual Growth Conference on Thursday, August 13, 2020, at 8:00 AM EDT.David Roberts, President, is scheduled to participate in the virtual 5th Annual Needham Med Tech & Diagnostics 1×1 Conference on Monday, August 17, 2020.About LeMaitre VascularLeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to ad...
LeMaitre Vascular, Inc. (LMAT) Q2 2020 Earnings Conference Call July 23, 2020 05:00 PM ET Company Participants Joseph Pellegrino - Chief Financial Officer, Treasurer and Secretary George LeMaitre - Chairman and Chief Executive Officer David Roberts - President Conference Call Participants Cecilia Furlong - Canaccord Genuity Group Inc. Andrew Ranieri...